Search Results
Feb 26, 2026, 19:24 ET Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics
TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts
More news about: Illumina
Feb 26, 2026, 19:01 ET Energy Fuels Announces 2025 Results and 2026 Guidance
come."Equally impressive has been our progress in rare earth processing and production. Energy Fuels' rare earth products have been confirmed, qualified, and used by manufacturers for EVs and hybrid EVs. In 2025, we made considerable investments in our rare earth segment. We strongly believe now is the time
More news about: Energy Fuels Inc.
Feb 26, 2026, 18:26 ET RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025, inclusive (the "Class Period"), of the important April 6, 2026 lead plaintiff deadline.So what:
More news about: THE ROSEN LAW FIRM, P. A.
Feb 26, 2026, 18:02 ET Study finds more parents saying 'No' to vitamin K, putting babies' brains at risk
is naturally low in newborns. It is not a vaccine. Vitamin K is needed to help blood clot. Getting a vitamin K shot right after birth can prevent a rare but serious condition called vitamin K deficiency bleeding. This condition can cause an intracerebral hemorrhage, a type of stroke, when a blood vessel
More news about: American Academy of Neurology
Feb 26, 2026, 17:31 ET Chondrosarcoma Treatment Market Forecasts Robust Growth During the Forecast Period (2026-2036) as Oncology Pipeline Strengthens | DelveInsight
radiotherapy.Currently, there is no approved therapy specifically for chondrosarcoma, underscoring a significant unmet need for effective treatments for this rare and aggressive cancer.The emerging therapeutic pipeline is limited, with investigational agents such as TIBSOVO (Servier), Ozekibart/INBRX-109
More news about: DelveInsight Business Research, LLP
Feb 26, 2026, 16:02 ET Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
development programs for three rare muscle diseases: myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). Avidity is also advancing two wholly-owned precision cardiology development candidates addressing rare genetic cardiomyopathies. In
More news about: Avidity Biosciences, Inc.
Feb 26, 2026, 15:43 ET Andakin Ventures Invests in Hibachi Worldwide to Accelerate Global Expansion of the In-Home Hibachi and Private Chef Entertainment Industry
excitement of hibachi to audiences around the world while honoring the craftsmanship passed down through generations.""Hibachi Worldwide represents a rare opportunity to scale a high-growth, experience-driven hospitality platform on a global scale," said
More news about: Andakin Ventures
Feb 26, 2026, 15:29 ET NEW BOOK ROBERT GODDARD'S MASSACHUSETTS HONORS THE CENTENNIAL OF THE WORLD'S FIRST MODERN ROCKET LAUNCH
that carried astronauts to the Moon, and the spacecraft now exploring the outer reaches of the solar system. The 2026 First Launch Centennial offers a rare moment to reflect on how one man's imagination helped open the space age.Robert Goddard's Massachusetts brings this iconic and inspirational
More news about: Lowell Observatory
Feb 26, 2026, 15:17 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadlines - RARE
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-ultragenyx-pharmaceutical-inc-of-class-action-lawsuit-and-upcoming-deadlines--rare-302698718.htmlSOURCE
More news about: Pomerantz LLP
Feb 26, 2026, 15:01 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
phosphoinositide 3-kinase delta (PI3Kδ) inhibitor, as a treatment for children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency." The press release said that "[t]he FDA raised an issue with the potential for underexposure in lower weight pediatric patients.
More news about: Pomerantz LLP
Feb 26, 2026, 14:50 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
for purported optimal effect.Inovio's lead product candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis ("RRP"), a life-long, rare disease of the respiratory tract caused by HPV infection. At all relevant times, Defendants touted the prospects of the U.S. Food and Drug Administration
More news about: Pomerantz LLP
Feb 26, 2026, 14:26 ET PHILLIPS TO PRESENT ALICE BABER: SACRED SPACES, A LANDMARK SELLING EXHIBITION TRACING THE ARTIST'S VISION FROM 1959-1981
early and mature styles, underscoring the full arc of her development before her life was tragically cut short at age 54 in 1982. The show includes rare early watercolors and oils from the early 1960s, seldom seen in the market and crucial to understanding Baber's stylistic transformation. Collectors
More news about: PHILLIPS
Feb 26, 2026, 13:00 ET Arna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform
formulation development and manufacturing to global marketing and commercialization. Our portfolio emphasizes niche dosage forms and treatments for rare and underserved diseases, reflecting our mission to address unmet medical needs with specialized focus on Respiratory Indications.About Slate
More news about: Slate Run Pharmaceuticals; Arna Pharma Inc.
Feb 26, 2026, 13:00 ET Wildbrine Launches Industry-First Fermented Bean Salad, Creating a New Category at the Intersection of Protein, Fiber and Probiotics
unprecedented and significant innovation in the fermentation space. The bright, savory Mediterranean and Kimchi-Style Fermented Chickpea Salads deliver a rare trifecta of protein, fiber, and live fermentation – all while maintaining the beans' natural bite and texture. The 20-ounce jars will be sold exclusively
More news about: wildbrine
Feb 26, 2026, 12:50 ET Cerecin Announces Publication of Clinical Study Demonstrating Promising Results of CER-0001 (tricaprilin) for Rare Pediatric Epilepsy
generally well tolerated and demonstrated seizure reduction in infants with rare drug-resistant epileptic spasms.Phase 1/2a study supports further development as a metabolic therapy for rare developmental and epileptic encephalopathy (DEE).DENVER,
More news about: Cerecin Inc.
Feb 26, 2026, 12:35 ET Polaris Slingshot Unveils Exclusive Signature Edition, Fusing Advanced Technology with One-of-a-Kind Styling
one-of-a-kind styling. The new limited-edition model takes everything that defines the high-performance R model and elevates it to something truly rare.
More news about: Polaris Slingshot
Feb 26, 2026, 12:15 ET /C O R R E C T I O N -- American College of Medical Genetics and Genomics/
Medical genetics plays a central role in today's healthcare, guiding the diagnosis of rare diseases, informing cancer risk, shaping newborn screening, and enabling precision treatment options. Yet many people are unfamiliar with the professionals
More news about: American College of Medical Genetics and Genomics
Feb 26, 2026, 11:56 ET Silver Demand Hits a Sixth Straight Deficit, The Supply Math Doesn't Add Up
Minerals list has further tightened the strategic narrative, as China controls an estimated 70% of global refined silver supply and added the metal to its rare-earth export controls in January[4].Americore Resources (TSXV: AMCO) (OTCQB: AMCOF) recently
More news about: USA News Group
Feb 26, 2026, 11:11 ET REMADE® Circular Economy Tech Summit & Conference to Convene March 11-12 in Washington, DC
Event Will Feature 50+ Innovations to Increase the Reuse, Remanufacturing, Recovery and Recycling of Critical Minerals, Rare Earth Elements and Other Key Materials ROCHESTER, N.Y., Feb. 26, 2026
More news about: REMADE Institute
Feb 26, 2026, 11:07 ET More Organ Donations Now Come from People Who Die After Their Heart Stops Beating
Feb. 26, 2026 /PRNewswire/ -- Organ donation after the heart stops beating, a practice called donation after circulatory death, has gone from rare to routine in the United States, a new study shows. This shift over the past 25 years, aided by technological advances, is helping to meet the growing
More news about: NYU Grossman School of Medicine and NYU Langone Health
Feb 26, 2026, 11:00 ET uniQure N.V. Stock Alert: QURE Stockholders Who Lost Money in the Company Should Contact Robbins LLP for Information on How to Recover Their Losses
N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases.
More news about: Robbins LLP
Feb 26, 2026, 11:00 ET ARUP Creates Innovation Central Laboratory To Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
patients with nonadvanced systemic mastocytosis. Other current initiatives of the ARUP Central Innovation Laboratory include developing assays for rare and underrecognized diseases, improving genomic sequencing technologies, operationalizing artificial intelligence (AI) and digital pathology solutions
More news about: ARUP Laboratories
Feb 26, 2026, 10:43 ET Scott Mitchell Named Managing Partner at SDR Ventures
putting the goals and needs of the founders and entrepreneurs who build great companies at the center of the M&A process is simple in concept but rare in practice."Under the leadership of Scott Mitchell and Geoff Eliason, SDR Ventures is poised to continue expanding its reach and enhancing its
More news about: SDR Ventures
Feb 26, 2026, 10:43 ET Cohen & Company Announces Appointment of Pawel Skonieczka as Managing Director to Lead Coverage of Space Technology, Aerospace, & Communications Infrastructure in Capital Markets Segment
will be driven by consolidation, scale, and disciplined capital deployment. All areas where our advisory platform is well-positioned. Pawel brings a rare combination of global sector experience and hands-on M&A and capital markets expertise that today's space companies increasingly require."Earlier
More news about: Cohen & Company Inc
Feb 26, 2026, 10:15 ET NBDF Launches "Educate to Elevate" Campaign with Celebrity Advocates to Raise Awareness of Bleeding Disorders
community and offering the opportunity for meaningful discussion around important topics. "I know how difficult it can be to live with a rare disease that isn't understood by the general public or even healthcare providers," said Greg Grunberg. "These are ordinary people who are often
More news about: National Bleeding Disorders Foundation